MKI67 and brain neoplasm: Sagiyama et al. demonstrated that amide signal proportionally decreased with Ki67 (a marker of cell proliferation) in brain tumor models following temozolomide (TMZ) treatment44, and the authors suggested that CEST MRI be used for the non-invasive detection of therapeutic response.